ZENYTH PARTNERS
ZENYTH PARTNERS is a Series C+ fund in US-Northeast writing up to $50M checks into Healthcare and healthcare-services.
- Stages
- Series C+
- Sectors
- Healthcare, healthcare-services
- Check size
- up to $50M
- Invests in
- US-Northeast
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $1.5B
- Website
- zenythpartners.com
Thesis
Zenyth Partners is a private equity firm founded in 2016 that focuses on the healthcare services and healthcare technology sectors, primarily in the Northeast U.S. With approximately $1.5 billion in assets under management and a second fund, Zenyth Partners II, closing at $375 million, the firm targets mid-market, growth-stage platforms. Their investment strategy involves building healthcare businesses from early stages into leading platforms by partnering with experienced management teams and leveraging operational expertise. They prefer majority control but will consider joint or minority stakes, investing from a permanent capital vehicle for a flexible, long-term horizon. Zenyth Partners emphasizes continuous improvement to elevate clinical standards and patient outcomes, aiming to create patient-centric, scalable, and operationally resilient healthcare organizations.
Common questions
Does ZENYTH PARTNERS invest at the Series C+ stage?
Yes. ZENYTH PARTNERS lists Series C+ among the stages it invests in.
What check size does ZENYTH PARTNERS write?
ZENYTH PARTNERS writes up to $50M checks.
Where does ZENYTH PARTNERS invest?
ZENYTH PARTNERS invests in US-Northeast.